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Background: Millions of people are at risk from the adverse effects of arsenic exposure through drinking water.
Increasingly, non-cancer effects such as cardiovascular disease have been associated with drinking water arsenic exposures.
However, most studies have been conducted in highly exposed populations and lacked individual measurements.
Objective: To evaluate the association between cardiovascular disease and well-water arsenic exposure.
Methods: We conducted a hospital based case control study in Inner Mongolia, China. Cases and controls were
prospectively identified and enrolled from a large hospital in the Hangjin Hou area. Cases were patients diagnosed with
cardiovascular disease and controls were patients free from cardiovascular disease, admitted for conditions unrelated to
arsenic exposure. Water from the primary water source and toenail samples were collected from each subject and tested
for inorganic arsenic.
Results: Arsenic exposures were moderate with mean and median arsenic exposures of 8.9 μg/L and 13.1 μg/L,
respectively. A total of 298 cases and 275 controls were enrolled. The adjusted odds ratio (AOR) and corresponding 95%
confidence interval (95% CI) for a 10 μg/L increase in water arsenic were 1.19 (95% CI: 1.03, 1.38). Compared to exposures
less than 10 μg/L, the AOR for water arsenic exposures above 40 μg/L was 4.05 (95% CI: 1.1-14.99, p = 0.04). Nail arsenic
above 1.38 μg/g was also associated with an increased risk of cardiovascular disease.
Conclusions: By using standardized case definitions and collecting individual measurements of arsenic, this study
addressed several limitations of previous studies. The results provide further evidence of the association between
cardiovascular disease and arsenic at moderate exposures.
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Worldwide, millions of people are at risk from the ad-
verse effects of arsenic exposure through drinking water.
Studies in Taiwan, Argentina and Chile have documented
increased bladder, lung and skin cancer mortality as a re-
sult of arsenic exposure [1-3]. More recently, exposure to
waterborne arsenic has been associated with non-cancer
health effects such as cardiovascular disease [4-8] and
neurological disorders [9-12].
Epidemiological studies have associated arsenic expo-
sures with cardiovascular and peripheral vascular health
effects including Blackfoot disease, hypertension, athero-
sclerosis, ischemic heart disease, vascular disease mortality,* Correspondence: wade.tim@epa.gov
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unless otherwise stated.and abnormal electrocardiograms (ECG), including pro-
longed QT-interval [13-16]. Acute arsenic toxicity is
known to cause cardiovascular effects including abnormal
ECGs [17] and ventricular fibrillation [18,19]. Arsenic tri-
oxide treatment for promyelocytic leukemia is also known
to cause prolonged QT intervals, a risk factor sudden car-
diac death, by blocking repolarizing potassium currents
[20,21]. Arsenic is believed to induce these cardiovascular
effects through several potential mechanisms including in-
flammation in vascular tissues, oxidative stress, endothelial
injury and smooth muscle cell proliferation [17].
Increased cardiovascular mortality was observed in popu-
lations in Taiwan exposed to extremely high levels of arsenic
in well water [6,13,16,22,23]. Most of these studies, however,
were retrospective, lacked individual measures of arsenic or
cardiovascular disease (CVD), and were conducted in popu-
lations with high arsenic exposures (e.g., >600 μg/L). Therehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wade et al. Environmental Health  (2015) 14:35 Page 2 of 10is increasing evidence that the cardiovascular effects of ar-
senic may manifest at considerably lower arsenic exposures.
Two recent studies in the United States observed associa-
tions with cardiovascular disease (CVD) and coronary heart
disease in populations exposed to only moderate levels of
arsenic (<100 μg/L) [24,25]. A recent review of the topic
concluded that at “low-moderate arsenic levels, high quality
prospective studies including individual-level exposure as-
sessment and standardized CVD outcomes are needed to
understand the role of arsenic as a CVD risk factor” [26].
In order to better understand the association between
waterborne arsenic and cardiovascular disease, especially at
low to moderate levels of exposure, we conducted a
hospital-based case control study in Inner Mongolia, China
in a population exposed to arsenic contaminated well water.
Methods
Study location
The study was conducted in the Bayingnormen (Ba Men)
region of Inner Mongolia, China. The Ba Men region isFigure 1 Study site.located on the Hetao Plain, north of the Huang He (Yel-
low) River in western Inner Mongolia, China (Figure 1). In
the late 1970s, the primary source of drinking water
shifted away from large shallow wells to deeper artesian
wells due to water scarcity and contamination of the shal-
low wells. These artesian wells were often contaminated
by naturally occurring arsenic. Characteristic arsenic-
induced skin lesions were reported in the region in the
early 1990s. Several studies have documented the preva-
lence of adverse health effects associated with arsenic ex-
posure in this region [4,27-29].
Ba Men is a rich agricultural region and most resi-
dents of the region are farmers. Ma et al. reported that
drinking water was the only significant source of arsenic
exposure and that arsenic containing pesticides had not
been used in the region [27]. Samples from soil, certain
foods (wheat, corn, sunflower seeds, beans, melon and
vegetables), and surface water were found to have ar-
senic levels lower than China national standards [30].
Rice, another potentially important source of inorganic
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this part of China than locally produced foods made
with wheat grain. According to our collaborators from
the region, rice is not grown locally. The residents occa-
sionally consume freshwater fish from the Huang He
River, and only very rarely seafood from the ocean [32].
Study site and population
We recruited cases with cardiovascular disease and con-
trols from a regional hospital in the Hangjin Hou
(Hang-Hou) area of Ba Men, Inner Mongolia (Figure 1).
Hang-Hou hospital serves a population base of ap-
proximately 300,000 from a region of approximately
1800 km2. Hang-Hou hospital is equipped with modern
facilities, including equipment necessary (echocardio-
gram and interventional laboratories) for diagnosing car-
diovascular disease. Cardiologists at the hospital reported
a minimum of 900 patients were admitted annually for
cardiovascular disease.
Enrollment and informed consent
Local medical staff trained on the study procedures,
protocols and consent processes described the study
and offered enrollment to newly admitted patients with
chest pain or suspected cardiovascular disease, as well
as to suitable potential controls. Patients interested in
participating were provided details about the study and
read and signed an informed consent form. Study ma-
terials and procedures were approved by the Institu-
tional Review Board for the University of North
Carolina at Chapel Hill (UNC). All study staff were
trained on the informed consent process and were pro-
vided training on the ethical treatment of human re-
search subjects. Ethical certification, approval and
permission to conduct the study were also obtained
from the Inner Mongolia Centers for Endemic Disease
Control and Research (IMCDC) and from the Director
of Hang-Hou hospital.
Following enrollment, clinical information and tests were
obtained if not available. Study staff administered a stan-
dardized questionnaire to acquire information regarding
personal and family health history, diet, other health habits
and behaviors, occupation and residence histories. Toenails
and/or fingernails were collected while the patient was in
hospital or at the subsequent home visit. Appointments
were scheduled to visit the patient home to collect water
samples. All home visits were conducted within one month
of enrollment at the hospital.
Case definition and selection
Inclusion criteria for cases were: 1) Between 18 and 70 years
of age; 2) Met one of the three case definitions (described
below) 3) Resident of Hang-Hou county. Potential caseswere excluded if they had severe valvular disease (e.g., aor-
tic stenosis).
Cases were defined as patients meeting any one of the
three following conditions:
1) Acute Myocardial Infarction (MI). Defined as having
2 of 3 findings:
Recent chest pain consistent with angina for
approximately 30 minutes or more.; ECG changes
consistent with MI: ST segment elevation greater
than or equal to 1.0 mV in 2 contiguous leads (2
leads following each other); Positive enzymes:
Elevation of CK/MB or troponin consistent with MI.
2) Cardiomyopathy. Defined ejection fraction less than
or equal to 35% without valvular heart disease.
3) Chest pain suggestive of angina with any one of the
following: changes on ECG consistent with previous
MI (Q-waves); documented enzyme changes
consistent with previous MI; changes in serial ECG
tracings (for example T-wave changes); ECG changes
on treadmill stress (exercise) testing consistent with
injury or ischemia.
The following criteria were used to determine an
abnormal treadmill stress test: ST segment elevation
greater than 1.0 mV in contiguous leads that do not
normally have Q waves (other than V1 or a VR); ST
depression greater than or equal to 2.0 mm which is
horizontal or downsloping measured ST segment
greater than or equal to 0.08 seconds after QRS
termination.
At the discretion of the attending physician, borderline
cases (i.e., cases with chest pain suggestive of angina but
no evidence of previous MI from ECG changes or en-
zymes) were asked to complete a treadmill stress test utiliz-
ing a standard Bruce protocol [33]. ECG tracings from the
stress test were used to confirm if the patient had ischemia
consistent with cardiovascular disease. Case reports, which
documented the physician’s diagnosis and assessment, re-
sults of relevant laboratory tests, a copy of the ECG and
echocardiogram, were translated to English by IMCDC
staff and provided to the study cardiologist who reviewed
and confirmed the cases. Cases which could not be con-
firmed to meet the criteria were excluded.
Control selection
Controls were between 18 and 70 years of age and resi-
dents of Hang-Hou County. Controls were frequency
matched to cases by sex and age (+/-5 years). Controls
were patients visiting Hang-Hou hospital without car-
diovascular disease as defined above and admitted for
conditions not known to be associated with arsenic ex-
posure. The exclusionary admission conditions included:
skin, lung, gastrointestinal (GI) tract and bladder cancers,
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sion (systolic blood pressure > 140; diastolic blood pres-
sure > 90), gangrene, amputation of limb or extremity
(resulting from gangrene or other peripheral vascular in-
sufficiency), and cirrhosis of the liver. Acceptable condi-
tions for control selection included, for example: injury,
childbirth, general exams, and infections. In addition to
patients admitted to the hospital, we considered out-
patient visitors as potential sources of controls, for ex-
ample patients reporting for routine examinations,
physicals or check-ups.
Screened subjects were excluded from qualifying as a
control if any of following were present: ECG showed
evidence of cardiovascular disease: existing heart disease;
peripheral vascular disease; abnormal left ventricular
ejection fraction on echocardiogram (<55%).Nail sample collection and arsenic measurement
Study subjects were asked to provide toenail samples
under the supervision of study staff in hospital or at
their place of residence using a clean nail clipper (pro-
vided by study staff ). One to 3 mm of toenail was col-
lected from each toe and pooled in a sealed plastic bag.
When toenails could not be collected, or a relatively
small amount of toenail was collected, fingernail clip-
pings were collected. Approximately 30% of subjects
provided nail samples at the subsequent home visit be-
cause their nails were too short at the time of their
hospital stay. Of the subjects with missing nail samples,
14 were not present at the time of the home visit be-
cause they had moved (n = 4) or were deceased (n = 10).
The remaining 26 either refused or did not have enough
nail for collection and analysis. Toenails were stored and
shipped to the United States Environmental Protection
Agency (EPA) laboratory in North Carolina at ambient
temperature for processing and aliquoting. The nail sam-
ples were cleaned as described previously [34] by sonifi-
cation in HPLC-grade water to remove debris from the
nail surface followed by acetone wash to dry and remove
additional organic contaminants. Toenails were analyzed
for arsenic using Instrumental Neutron Activation Ana-
lysis (INAA) at North Carolina State University Nuclear
Services Department (Raleigh, NC, USA) [35]. Samples
were tested in triplicate and the average result, detection
limit and uncertainty was reported for each sample. The
average limit of detection was 0.16 μg/g and the average
uncertainty was 15%.
Fewer than 6% of nail samples were below the limit





. Nail samples had a variable limit of detection
dependent on the mass of the sample. When possible,
toenails were used for nail arsenic measurements. For
28 subjects of the 566 that provided nail samples (<5%),only fingernail samples were collected. Because in these
samples, fingernail and toenail arsenic were highly cor-
related for those who provided both (r = 0.73), regres-
sion coefficients of a regression model of toenail
arsenic with fingernail arsenic and age as independent
variables were used to impute values for missing toenail
arsenic samples (single imputation procedure) for the
28 subjects that provided fingernail but not toenail
samples according to the following regression model:
Toenail Arsenic (μg/g) = 0.988 + (0.8165 × Fingernail
Arsenic (μg/g))-(0.0108 × Age (years)).Water sample collection and arsenic measurement
At the time of the home visit, study staff collected sam-
ples of water from the primary drinking water source.
Subjects were assigned a water arsenic exposure based
on their primary source of drinking water. Samples were
collected in acid-washed tubes, transported to the
University of Alberta on blue ice and analyzed for total
arsenic using inductively coupled plasma mass spec-
trometry (ICPMS) as described previously [36]. For
shared wells or subjects using distributed or municipal
water, a single sample was collected and tested to repre-
sent arsenic exposures. The detection limit by ICPMS
was 0.1 μg/L. The average coefficient of variation was
1.9%. Two water arsenic samples were measures below





Covariate measurement and assessment
In addition to age category and sex, the following covari-
ates were considered in multivariate models as potential
confounders of the association between arsenic and car-
diovascular disease: diet, body mass index (BMI); occu-
pation (unemployed, farming, industry, professional and
other); education (None or some primary school; primary or
some high school; completed high school); smoking (non-
smoker, former smoker, or current smoker); alcohol use (yes
or no); and family history of hypertension, diabetes or heart
disease. With the exception of BMI, which was based on
measured height and weight in the hospital, these were de-
rived from responses to the questionnaire and interview.
To account for diet, subjects were asked how often in
a month they usually eat various types of foods including
fish, beef, grains, pork, beans, vegetables and fruit. For
analysis, these responses were combined into summary
estimates of servings per month for fruits and vegeta-
bles; protein other than meat (milk, soy) and meat (beef,
chicken, pork, other meat) by assigning numerical values
of 0; 0.5; 3; and 10 servings to the categorical responses
never, less than 1, 1 to 5 and over 5, respectively. Be-
cause nearly all subjects reported eating grain (rice,
wheat or corn) regularly, it was not included in add-
itional analysis.
Wade et al. Environmental Health  (2015) 14:35 Page 5 of 10Statistical analysis
Cardiovascular disease case status (present or absent) and
arsenic measures (nail and water) were the outcome and
exposures of interest. Tabulations of nail and water arsenic
categories and case/control status were compared with
demographic and health characteristics (smoking, age, sex,
income, occupation, diet) to identify correlates of cardio-
vascular disease and water and nail arsenic.
Logistic regression models were used to assess the as-
sociation between case status and arsenic exposures con-
trolling for the variables described above. Models were
fit with all the variables and a final model was selected
by sequential backwards removal of each variable, maxi-
mizing the Akaike’s information criterion (AIC) [37].
Only alcohol use was excluded by the selection procedure,
so all models included age, sex, diet, BMI, occupation, edu-
cation, smoking, and family history of hypertension, dia-
betes or heart disease. Water arsenic and nail arsenic were
modeled as continuous variables and also as categorical
variables. Water arsenic was categorized as follows: less
than 10; 10-40 and over 40 μg/L. These categories were
based on the current EPA regulatory standard [38] and
World Health Organization guideline value [39] of 10 μg/L
for the lowest category and just below the previous EPA
standard of 50 μg/L for the upper category. Because there
was a limited range of exposure, additional categories were
not considered. Nail arsenic was categorized based on per-
centiles of the distribution to contrast the lowest exposures
and the highest exposures as follows: 0.11-0.28 μg/g (<10th
percentile); 0.29-1.37 μg/g (11-90th percentile) and 1.38-
34.2 μg/g (>90th percentile).
Study population and recruitment
Case and control recruitment began in July 2006 and
ended in December 2011. In total 344 cases and 275
controls were recruited. Forty-five cases were excluded
following review because they did not meet case criteria,
leaving 298 cases. The general older age of cardiovascu-
lar disease patients and the younger age of most accept-
able controls (injuries, pregnancy, infections), resulted in
fewer controls than originally anticipated.
Of the 298 cardiovascular cases, 22 met the case defin-
ition of cardiomyopathy; 207 for acute MI; and 75 for
previous MIs. Six of the cardiomyopathy cases also met
criteria for a previous MI. The most common types of
admissions for controls were upper respiratory symp-
toms (colds, flu, allergies), injuries, gastrointestinal
symptoms, and regular examinations.
Results
Characteristics of cases and controls are shown in Table 1.
More cases reported smoking, having a family history of
diabetes, hypertension or heart disease (Table 1), and eat-
ing beef, pork and animal fat (data not shown). Cases alsohad a higher average BMI (24.6 vs. 23.8) and 26% of
cases had a BMI above 26 compared to 16% of controls.
Cases were also slightly older than controls (mean age
57.4 vs. 54.8).
Water arsenic
Water arsenic measures were available for a total of 560
subjects, 288 cases (51%) and 272 controls (49%). Most
subjects were on piped water or municipal water (83%),
and 17% relied on a well as their primary source of
drinking water. Water arsenic exposures ranged from
below detection (n = 2) to 208.1 μg/L. The overall me-
dian and mean water arsenic levels were 8.9 and
13.1 μg/L, respectively. Only 4 subjects had water ar-
senic measures above 100 μg/L (Table 2).
Water arsenic was slightly higher among municipal
water users (mean = 13.6 μg/L; median 9.9 μg/L) com-
pared to well water users (mean = 10.8 μg/L; median
3.1 μg/L); although more well water users had water ar-
senic above 40 μg/L (6% vs 3% above 40 μg/L for well
water and municipal water, respectively). Water arsenic
was inversely associated with frequency of pork and beef
consumption, and education. Never smokers and non-
users of alcohol and unemployed subjects had slightly
higher water arsenic exposures. No differences in water
arsenic was evident by age, sex and family history of
heart disease (Additional file 1: Table S1).
Nail arsenic
Toenail arsenic measures were available or imputed
from fingernail measures for a total of 533 subjects, 277
cases (52%) and 256 controls (48%). Toenail arsenic
levels ranged from 0.18 μg/g to 34μg/g. Median and
mean levels were 0.60 μg/g and 0.87μg/g, respectively.
Log transformed water and nail arsenic measures were
only slightly correlated (r = 0.12, p = 0.007). The correl-
ation was stronger among subjects with water arsenic
measures above 20 μg/L (n = 126, r = 0.45, p < 0.00005).
Males had slightly higher nail arsenic and current
smokers had higher nail arsenic compared to former or
never smokers (Additional file 1: Table S1). Nail arsenic
also varied by occupation and in also contrast to water ar-
senic, professionals had the highest levels of nail arsenic
and farmers had the lowest (Additional file 1: Table S1).
Cardiovascular case status and water arsenic
Although few subjects had high levels of arsenic expos-
ure, more cases compared to controls had water arsenic
above 40 and 50 μg/L (Table 2). Fifteen of 19 subjects
with water arsenic above 40 μg/L were cases and all four
subjects with water arsenic above 100 μg/L were cases.
Overall mean and median water arsenic measures were
13.2 and 7.5 μg/L among cases and 13.0 and 9.7 μg/L
among controls.
Table 1 Characteristics of cases and controlsa
Control (N = 275) Case (N = 298) Total (N = 573)
N(%) N(%) N(%)
Sex
Male 185 (67%) 209 (70%) 394 (69%)
Female 90 (33%) 89 (30%) 179 (31%)
Age
21-40 23 (8%) 21 (7%) 44 (8%)
41-50 59 (22%) 49 (16%) 108 (19%)
51-60 104 (38%) 91 (31%) 195 (34%)
61-70 89 (32%) 137 (46%) 226 (39%)
Occupation
Unemployed 41 (15%) 19 (7%) 60 (11%)
Farming 116 (42%) 185 (64%) 301 (54%)
Industry 19 (7%) 23 (8%) 42 (8%)
Professional 49 (18%) 41 (14%) 90 (16%)
Other 50 (18%) 20 (7%) 70 (12%)
Smoking
Never Smoker 134 (49%) 86 (30%) 220 (39%)
Former Smoker 25 (9%) 91 (31%) 116 (21%)
Current Smoker 115 (42%) 115 (39%) 230 (41%)
Drinks Alcohol
No 164 (60%) 158 (54%) 322 (57%)
Yes 111 (40%) 135 (46%) 246 (43%)
Family history of cardiovascular disease
No 227 (83%) 141 (48%) 368 (65%)
Yes 48 (18%) 152 (52%) 200 (35%)
Education
None or some primary school 65 (24%) 97 (33%) 162 (29%)
Some high school 125 (46%) 139 (48%) 142 (25%
Completed high school 85 (31%) 57 (20%) 142 (25%)
Body Mass Index (quartiles)
15.7-22.2 78 (28%) 65 (22%) 143 (25%)
22.3-24.1 76 (28%) 69 (23%) 145 (25%)
24.2-25.9 78 (28%) 76 (26%) 154 (27%)
26.0-36.5 43 (16%) 88 (30%) 131 (23%)
Years using at current residence (mean) 17.1 18.3 17.8
Estimated monthly servings (mean)
Fruits and vegetables 16.7 14.3 15.4
Meat 20.3 21.8 21.1
(beef, pork, poultry)
Other protein 15.8 12.6 14.1
(beans, milk, eggs)
aNumbers do not add to 275 cases and 298 controls for some categories due to missing data. Column percents may not add to 100% due to rounding.
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Table 2 Case status and arsenic exposure categories
Water Arsenic (μg/L) Control Case Toenail arsenic Toenail arsenic
(μg/g) (μg/g)
Mean/Median Min/Max
Under 10 137 (50.4%) 168 (58.3%) 0.77/0.57 0.18/16.4
11-39 131 (48.2%) 105 (44.5%) 0.94/0.59 0.13/34.2
40 -99 4 (1.5%) 11 (3.8%) 1.41/1.60 0.40/2.46
100 and over 0 (0%) 4 (2.2%) 3.38/342 2.72/3.95
Toenail Arsenic (μg/g) Control Case Water arsenic Water arsenic
(μg/L) (μg/L)
Mean/Median Min/Max
0.11-0.28 19 (8%) 32 (12%) 10.2/2.94 0.34/31.5
(<10th percentile)
0.29-1.37 212 (85%) 194 (74%) 11.8/9.00 0.29/88.3
(10th-90th percentile)
1.38-34.21 18 (1.5%) 35 (13%) 29.0/10.8 0.42/208
(>90th percentile)
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modeled as a continuous and categorical exposure are
shown in Table 3. After adjustment for age, sex, smoking,
diet, family risk factors and BMI, the adjusted odds ratio
(AOR) for a 10 μg/L increase in water arsenic was 1.19
(95% CI: 1.03, 1.38). Other factors associated with caseTable 3 Adjusted odds ratios (AOR) for cardiovascular disease
AOR 95% CI
Continuous exposures
Water arsenic (10 μg/L) 1.19 1.03-1.38





40 and over 4.05 1.10-14.99







Ref: 0.11-0.28 1.91 0.73-4.99
Ref : 0.11-1.37 2.48 1.18-5.20
aCovariates for multivariate models included diet, body mass index (BMI); occupatio
(None or some primary school; primary or some high school; completed high schoo
of hypertension, diabetes or heart disease. Full models are available in Additional fi
bp-value for trend across categories.
cNumbers do not add to 573 due to missing data on water arsenic (n = 13), nail arsstatus included family risk factors for cardiovascular disease
and history of smoking (Additional file 1: Table S2 and S3).
Positive associations were also observed using log-10 trans-
formed water arsenic (AOR =1.54, 95% CI: 1.09-2.17).
Relative to water arsenic exposure less than 10 μg/L,
there were elevated AORs for water arsenic exposuresand water and nail arsenic exposurea











n (unemployed, farming, industry, professional and other); education
l); smoking (non-smoker, former smoker, or current smoker); and family history
le 1.
enic (n = 40), or one more covariates.
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Table 3) and 50 μg/L (AOR 5.20 (p = 0.1; 95% CI 0.9-29.99).Cardiovascular case status and nail arsenic
Overall mean and median nail arsenic measures were
0.96 and 0.58 μg/g among cases and 0.79 and 0.60 μg/g
among controls. A higher proportion of cases had nail
arsenic above the 90th percentile (1.38-34.2 μg/g) com-
pared to controls (13% vs. 1.5%, Table 2). After adjust-
ing for covariates there was a positive association
between nail arsenic and case status (AOR for 1 μg/g
increase in nail arsenic = 1.16, 95% CI 0.98-1.38,
Table 3). In the categorical analysis, nail arsenic above
the 90th percentile compared to the 10th percentile was
positively associated with case status (AOR = 1.9, 95%
CI 0.73-4.99, Table 3). When those above 90th percent-
ile are compared with all subjects below the 90th per-
centile, the risk was stronger and statistically significant
(AOR = 2.75; 95% CI 1.33-5.69, Table 3).Discussion
In recent years, health officials in Hangjin Hou, like other
arsenic affected areas of Inner Mongolia, have focused on
improving water quality and reducing arsenic exposures. In
this study, water arsenic levels were lower than previously
documented [4,28], and few subjects were exposed to over
water over 100 μg/L. Despite these relatively moderate
water arsenic exposures, we observed an association be-
tween well water arsenic and cardiovascular disease. The
odds of having cardiovascular disease among those with
drinking water arsenic above 40 μg/L was four times higher
compared to those with drinking water less than 10 μg/L.
Although we lacked sufficient data to evaluate departures
from non-linearity and threshold effects below 40 μg/L,
under the assumption of a linear trend, a 10 μg/L increase
in water arsenic was associated with a 19% increase in the
odds of cardiovascular disease.
Nail arsenic exposures were also lower than we ob-
served previously in this region, however the median
levels were approximately 10-fold higher than those ob-
served in a study in the US [40]. Although we did not
observe an effect of nail arsenic under 1.38 μg/g, sub-
jects with the highest levels of nail arsenic had a greater
incidence of cardiovascular disease. Water arsenic was
more strongly associated cardiovascular disease in terms
of the linear trend, which was not statistically significant
for nail arsenic. We also observed only a slight correl-
ation between nail arsenic and water arsenic (r = 0.17),
although the correlation was considerably improved at
higher water arsenic exposures above 20 μg/L (r = 0.45).
The discrepancy at lower exposures may reflect recent
switching of water sources, or exposures to other non-
water sources of arsenic.Results of this study are consistent with increasing evi-
dence of associations between arsenic and cardiovascular
disease at low to moderate levels of chronic arsenic ex-
posure. In the United States, two recent studies have ob-
served associations between heart disease and arsenic
exposures under 100 μg/L. In south-central Colorado, a
retrospective cohort study observed an association between
time-weighted average lifetime exposure of arsenic and
coronary heart disease in a region with drinking water ar-
senic under 100 μg/L [24]. Also, an analysis from the
Strong Heart Study found an association with cardiovascu-
lar disease and urinary arsenic among American Indian
communities in Arizona, Oklahoma and North and South
Dakota [25]. Increases in blood markers of cardiovascular
disease risk and inflammation have also been observed at
low to moderate levels of exposure [4,40-42]. In Spain, ar-
senic at levels below 150 μg/L in municipal drinking water
has been associated with cardiovascular mortality [43].
In this study, one limitation is that we lacked information
on prior water exposures. While this likely introduced ex-
posure misclassification, the impact of this bias may miti-
gated for several reasons. Subjects had been at their
current residence a median of 20 years and a mean of
30 years and previous studies have described this region as
a relatively stable population with low migration [4,44].
Also, well water arsenic levels in this area appear to be
stable, and we previously reported samples from 57 wells
collected 12 years apart collected from Shahai village in
Hang-Hou were well correlated (r = 0.76, p < 0.0005) [28].
The latency period between arsenic exposure and the onset
of cardiovascular disease is likely considerably less than
that for cancer, which can be up to 20 or 30 years. In Chile,
it was found that increased acute myocardial infarction
mortality began concurrently with high arsenic exposures
and were maintained for 10 years, compared to lung and
bladder cancers which were not elevated until 20 years fol-
lowing the high exposures [8].
In this study we were able to account for many risk
factors for cardiovascular disease, we individually and
consistently diagnosed cases and controls, and individu-
ally measured arsenic exposure, thereby reducing mis-
classification. By using incident cases, a hospital based
case-control design and restricting cases to residents of
the Hang-Hou region, we were able to ensure that cases
and controls were recruited from the same general
population. Using incident cases rather than prevalent
cases helped reduce the time between exposure assess-
ment and the occurrence of cardiovascular disease
though, as with most case-control studies, we cannot be
certain that exposure preceded disease.
The study was limited in that few subjects were ex-
posed to high levels of arsenic. We were able to partially
control for the effects of age and sex by design through
matching, but there were other strong risk factors associated
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age, diet, family history and smoking history, were all associ-
ated with cardiovascular disease. Notably, those who quit
smoking were at considerably higher increased risk for car-
diovascular disease compared to non-smokers or current
smokers, possibly reflecting those who quit smoking due to
health concerns (Additional file 1: Tables S2-S5). It is possible
that we were unable to fully control for these and other fac-
tors associated with arsenic exposure and cardiovascular dis-
ease. In addition, as a result of few subjects exposed to high
arsenic levels, confidence bounds on our estimates of risk are
wide, resulting in imprecision in our risk estimates.
Conclusions
In a case-control study in Inner Mongolia, China, drink-
ing water arsenic was associated with increased risk of
cardiovascular disease among residents exposed to mod-
erate levels of arsenic. The results of this study provide
further evidence of the association between cardiovascu-
lar disease and arsenic at relatively moderate exposures.
Additional file
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characteristic. Table S2. Adjusted odds ratios (AOR) for cardiovascular
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Adjusted odds ratios (AOR) for cardiovascular disease and water arsenic
(categorical exposure model). Table S4. Adjusted odds ratios for
cardiovascular disease and nail arsenic (continuous exposure model).
Table S5. Adjusted odds ratios for cardiovascular disease and nail arsenic
(categorical exposure model).
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